Print Page  |  Close Window

Events & Presentations

September 2017?
Calendar Help
This calendar contains six months of past and future company related information, which may include press releases, SEC filings, calendar events and more. Dates containing information are indicated by a colored background. Please select a highlighted date from the calendar to see date-specific company information, including a link to additional information. This calendar requires JavaScript to be installed and activated on your browser.
Calendar Icon Legend:
Analyst Meeting
Conference
Conference Presentation
Corporate Conference Call
Custom Events
Earnings Conference Call
Earnings Release
Financial Reports
Mergers & Acquisition Announcement
Guidance Announcement
Other Corporate
Sales Call/Presentation
Sales Release
Shareholders Meeting
News Release
SEC Filings
Presentations
52 Week High
Today
SMTWTFS
-5-4-3-2-11
September 01, 2017
S-3
Formats:  Excel HTML Adobe PDF Word
CT ORDER
Formats:  HTML Adobe PDF Word
2
345
September 05, 2017
Investor Presentation
Formats:  PDF
6789
101112
September 12, 2017
4
Formats:  HTML Adobe PDF Word
13141516
17181920212223
24252627282930
Calendar Instructions
Please select a highlighted date from the calendar to view company related information. This calendar requires JavaScript to be installed and activated on your browser.

Upcoming Events

DateTitleRemind
Me
Prior to
Event
September 26, 2017
8:35 a.m. ET
2017 Cantor Fitzgerald Global Healthcare Conference
days
Enter your e-mail address 

Past Events

DateTitle
May 30, 2017
8:00 a.m. ET
Protagonist Business Update
Description: Event date and time: May 30, 2017 at 8:00 AM EDT
Webcast link: http://edge.media-server.com/m/p/bbh32fun
Teleconference details: toll-free 844-515-9178 or toll call +1-614-999-9313, conference ID number 30341699
May 25, 2017
10:00 a.m. PT
Annual Meeting of Stockholders
Location: Conference Center
Pacific Research Center
7677 Gateway Blvd.
Newark, CA 94560
Supporting 
Materials: 
Download Event Supporting Material Protagonist - 2017 Proxy Statement
May 6, 2017
through
05/09/17
Digestive Diseases Week
Description: Presentation Title: The Biomarker Profile of PTG-200, an Oral Peptide Antagonist of IL-23 Receptor, Tracks with Efficacy in a Preclinical Model of IBD
Date and Time: Saturday, May 6 from 11:15 AM to 11:30 AM CT
Location: McCormick Place, Room S102d
Location: Chicago, Illinois
April 24, 2017
through
04/25/17
Oxford Global’s 4th Annual Peptide Congress
Description: Session: Advances in Peptide Therapeutics
Presentation: Discovery & Development of PTG-100, an Oral Peptide Antagonist of α4β7 Integrin, in Clinical Development for the Treatment of Inflammatory Bowel Disease
Presenter: Ashok Bandari, Ph.D., Vice President, Chemistry, Protagonist Therapeutics
Date and Time: 9-9:30 AM BST, Tuesday April 25
Room: Conference Room 3- Epernay
Location: London, UK, Novotel London West
April 23, 2017
through
04/27/17
Drug Discovery Chemistry
Description:

Presentation: Biomarker Discovery and Development of PTG-200, an Oral Peptide Antagonist of IL-23 Receptor
Meeting: 8th Annual Inflammation Inhibitors: Small Molecule Approaches for Oral-based Therapeutics
Presenter: Larry Mattheakis, Ph.D., Vice President, Biology, Protagonist Therapeutics Date and Time: 10:35 am PT, Monday April 24

Presentation: Discovery & Development of PTG-100, an Oral Peptide Antagonist of α4β7 Integrin, for the Treatment of Inflammatory Bowel Disease
Meeting: 5th Annual Macrocyclics and Constrained Peptides: Bigger, Better and Still Oral Small Molecules
Presenter: Ashok Bandari, Ph.D., Vice President, Chemistry, Protagonist Therapeutics Date and Time: 2:20 PM PT, Wednesday April 26

Location: San Diego, CA, Sheraton San Diego Hotel and Marina
March 21, 2017
2:10 p.m. ET
Oppenheimer & Co. Healthcare Conference
Location: Westin New York Grand Central hotel, New York, NY.
March 14, 2017
2:05 p.m. ET
Barclays Global Healthcare Conference 2017
Description: Presenting: Dinesh V. Patel, Ph.D., Protagonist President and Chief Executive Officer
Location: Miami, FL, Loews Miami Beach Hotel
February 16, 2017
11:00 a.m. ET
Leerink Partners 6th Annual Global Healthcare Conference
Description: Presenting: Dinesh V. Patel, Ph.D., Protagonist President and Chief Executive Officer
Location: New York, NY, Lotte New York Palace
February 15, 2017
through
02/18/17
12th Congress of ECCO (European Crohn's and Colitis Organisation)
Description:
Poster Number: P113
Poster Title: Model based predictions of the PTG-100 pharmacodynamic responses in Ulcerative Colitis patients
Date and Time: February 17, 2017 12:30-13:30
Presenting Author: Larry Mattheakis


Poster Number: P001
Poster Title: The Biomarker Profile of PTG-200, an Oral Peptide Antagonist of IL-23 Receptor, Tracks with Efficacy in a Preclinical Model of IBD
Date and Time: February 17, 2017 12:30-13:30
Presenting Author: Lili Cheng
Location: Barcelona, Spain
December 14, 2016
2:20 p.m. ET
BMO Capital Markets, Prescriptions for Success Healthcare Conference
Location: New York, NY
December 8, 2016
through
12/09/16
2016 Advances in Inflammatory Bowel Diseases, Crohn’s & Colitis Foundation of America’s Clinical & Research Conference
Description:
Poster Number: P-271
Poster Title: The Biomarker Profile of PTG-200, An Oral Peptide Antagonist of IL-23 Receptor, Correlates with Efficacy in Preclinical Models of IBD
Date and Time: Friday, December 9, 2016 06:00 PM - 07:00 PM ET
Poster Location: Exhibit Hall - Atlantic B-C
Location: Orlando, FL
November 7, 2016
through
11/09/16
BioEurope 2016
Location: Cologne Germany
October 15, 2016
through
10/19/16
UEG Week
Description:
Poster Number: P0298
Poster Title: Safety, Pharmacokinetics and Pharmacodynamics of the Novel Oral Peptide Therapeutic PTG-100 (alpha4-beta7 Integrin Antagonist) in Normal Healthy Volunteers
Date and Time: Monday October 17, 10:30 - 17:00, presentation 12:30 - 13:30 CET
Presenting Author: Richard S. Shames, MD, Protagonist Chief Medical Officer


Poster Number: P0792
Poster Title: Pharmacokinetics and Pharmacodynamics Following Oral Administration of PTG-100, a Peptide Antagonist of Integrin alpha4-beta7
Date and Time: Tuesday October 18, 9:00 to 17:00, presentation 12:30 - 13:30 CET
Presenting Author: Thamil Annamalai, M.S., Protagonist Senior Director, Preclinical Development
Location: Vienna Austria
August 23, 2016
10:00 a.m. ET
Protagonist Therapeutics Inc at 252nd American Chemical Society National Meeting & Exposition
Location: Philadelphia, PA



View Protagonist Therapeutics Archived Events (Pre-IPO)


Presentation

Investor Presentation